Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Cardiology Reports
Erschienen in: Current Cardiology Reports 7/2023

24.05.2023 | Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systematic Review

verfasst von: Faiza Babar, Abdul Manan Cheema, Zubair Ahmad, Azza Sarfraz, Zouina Sarfraz, Huma Ashraff, Hamnah Tayyab, Ali Mustafa Bajwa, Haider Ali, Muzna Sarfraz, Anum Shahzad, Syed Rafay Ali Sabzwari

Erschienen in: Current Cardiology Reports | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This study aims to evaluate the sensitivity and specificity of wearable devices for AF detection in older adults, as well as examine the incidence of AF across various studies, contextual factors impacting AF detection, and safety and adverse events associated with wearable use.

Recent Findings

A systematic search of three databases identified 30 studies on wearables for AF detection in older adults, encompassing 111,798 participants. Both PPG-based and single-lead electrocardiography-based wearables show scalable potential for screening and managing AF.

Summary

The results of this systematic review demonstrate that wearable devices, such as smartwatches, can effectively identify arrhythmias like AF in older adults, with scalable potential in PPG-based and single-lead electrocardiography-based wearables. As wearable technologies continue to gain prominence in healthcare, it is crucial to understand their challenges and incorporate them as preventative and monitoring tools for AF detection in elderly populations to improve patient care and prevention techniques.
Literatur
1.
Khasnis A, Thakur RK. Atrial fibrillation: a historical perspective. Cardiol Clin. 2009;27:1–12.PubMedCrossRef
2.
Alshehri AM. Stroke in atrial fibrillation: review of risk stratification and preventive therapy. J Family Community Med. 2019;26:92.PubMedPubMedCentral
3.
Patel NJ, Atti V, Mitrani RD, Viles-Gonzalez JF, Goldberger JJ. Global rising trends of atrial fibrillation: a major public health concern. Heart. 2018;104:1989–90.PubMedCrossRef
4.
Stewart S, Murphy N, Walker A, McGuire A, McMurray JJV. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004;90:286–92.PubMedPubMedCentralCrossRef
5.
Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, Oikonomou E, Tousoulis D. Atrial fibrillation: pathogenesis, predisposing factors, and genetics. Int J Mol Sci. 2021;23:6.PubMedCrossRef
6.
Margulescu AD, Mont L. Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management. Expert Rev Cardiovasc Ther. 2017;15:601–18.PubMedCrossRef
7.
Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120:1501–17.PubMedPubMedCentralCrossRef
8.
Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5.PubMedCrossRef
9.
Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469–73.PubMedCrossRef
10.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8.PubMedCrossRef
11.
García-Fernández A, Roldán V, Marín F. Strategies for prediction and early detection of atrial fibrillation: Present and future. Europace. 2017;19:515–7.PubMed
12.
Engbers MJ, Vlieg AVH, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010;8:2105–12.PubMedCrossRef
13.
Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J R Coll Physicians Edinb. 2012;42:5–22.PubMedCrossRef
14.
Bayoumy K, Gaber M, Elshafeey A, Mhaimeed O, Dineen EH, Marvel FA, et al. Smart wearable devices in cardiovascular care: where we are and how to move forward. Nat Rev Cardiol. 2021;18:581–99.PubMedPubMedCentralCrossRef
15.
Charlton PH, Kyriacou PA, Mant J, Marozas V, Chowienczyk P, Alastruey J. Wearable photoplethysmography for cardiovascular monitoring. Proc IEEE. 2022;110:355–81.CrossRef
16.
Xintarakou A, Sousonis V, Asvestas D, Vardas PE, Tzeis S. Remote cardiac rhythm monitoring in the era of smart wearables: present assets and future perspectives. Front Cardiovasc Med. 2022;9.
17.
Pereira T, Tran N, Gadhoumi K, Pelter MM, Do DH, Lee RJ, et al. Photoplethysmography based atrial fibrillation detection: a review. NPJ Digit Med. 2020;3:3.PubMedPubMedCentralCrossRef
18.
Dagher L, Shi H, Zhao Y, Marrouche NF. Wearables in cardiology: here to stay. Hear Rhythm. 2020;17:889–95.CrossRef
19.
Quinn FR, Gladstone DJ, Ivers NM, Sandhu RK, Dolovich L, Ling A, et al. Diagnostic accuracy and yield of screening tests for atrial fibrillation in the family practice setting: a multicentre cohort study. Can Med Assoc Open Access J. 2018;6:E308–15.
20.
Kyriacou PA. Introduction to photoplethysmography. Photoplethysmography: Elsevier; 2022. p. 1–16.CrossRef
21.
Allen J. Photoplethysmography and its application in clinical physiological measurement. Physiol Meas. 2007;28:R1.PubMedCrossRef
22.
Smuck M, Odonkor CA, Wilt JK, Schmidt N, Swiernik MA. The emerging clinical role of wearables: factors for successful implementation in healthcare. NPJ Digit Med. 2021;4:45.PubMedPubMedCentralCrossRef
23.
24.
Lubitz SA, Faranesh AZ, Selvaggi C, Atlas SJ, McManus DD, Singer DE, et al. Detection of atrial fibrillation in a large population using wearable devices: the Fitbit heart study. Circulation. 2022;146:1415–24.PubMedPubMedCentralCrossRef
25.
Zhang S, Xian H, Chen Y, Liao Y, Zhang N, Guo X, et al. The auxiliary diagnostic value of a novel wearable electrocardiogram-recording system for arrhythmia detection: diagnostic trial. Front Med. 2021;8: 685999.CrossRef
26.
Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381:1909–17.PubMedPubMedCentralCrossRef
27.
Jacobsen M, Dembek TA, Ziakos A-P, Gholamipoor R, Kobbe G, Kollmann M, et al. Reliable detection of atrial fibrillation with a medical wearable during inpatient conditions. Sensors. 2020;20:5517.PubMedPubMedCentralCrossRef
28.
Heo NJ, Rhee SY, Waalen J, Steinhubl S. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes. Cardiovasc Diabetol. 2020;19:1–7.CrossRef
29.
Reverberi C, Rabia G, De Rosa F, Bosi D, Botti A, Benatti G. The RITMIATM smartphone app for automated detection of atrial fibrillation: accuracy in consecutive patients undergoing elective electrical cardioversion. Biomed Res Int. 2019;2019.
30.
Haverkamp HT, Fosse SO, Schuster P. Accuracy and usability of single-lead ECG from smartphones-a clinical study. Indian Pacing Electrophysiol J. 2019;19:145–9.PubMedCrossRef
31.
Dörr M, Nohturfft V, Brasier N, Bosshard E, Djurdjevic A, Gross S, et al. The WATCH AF trial: SmartWATCHes for detection of atrial fibrillation. JACC Clin Electrophysiol. 2019;5:199–208.PubMedCrossRef
32.
Wang L, Nielsen K, Goldberg J, Brown JR, Rumsfeld JS, Steinberg BA, et al. Association of wearable device use with pulse rate and health care use in adults with atrial fibrillation. JAMA Netw Open. 2021;4:e215821–e215821.PubMedPubMedCentralCrossRef
33.
Proesmans T, Mortelmans C, Van Haelst R, Verbrugge F, Vandervoort P, Vaes B. Mobile phone–based use of the photoplethysmography technique to detect atrial fibrillation in primary care: diagnostic accuracy study of the fibricheck app. JMIR MHealth UHealth. 2019;7: e12284.PubMedPubMedCentralCrossRef
34.
Himmelreich JCL, Karregat EPM, Lucassen WAM, van Weert HCPM, de Groot JR, Handoko ML, et al. Diagnostic accuracy of a smartphone-operated, single-lead electrocardiography device for detection of rhythm and conduction abnormalities in primary care. Ann Fam Med. 2019;17:403–11.PubMedPubMedCentralCrossRef
35.
William AD, Kanbour M, Callahan T, Bhargava M, Varma N, Rickard J, et al. Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: The iREAD Study. Hear Rhythm. 2018;15:1561–5.CrossRef
36.
Tison GH, Sanchez JM, Ballinger B, Singh A, Olgin JE, Pletcher MJ, et al. Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiol. 2018;3:409–16.PubMedCrossRef
37.
McManus DD, Chong JW, Soni A, Saczynski JS, Esa N, Napolitano C, et al. PULSE-SMART: pulse-based arrhythmia discrimination using a novel smartphone application. J Cardiovasc Electrophysiol. 2016;27:51–7.PubMedCrossRef
38.
Wasserlauf J, You C, Patel R, Valys A, Albert D, Passman R. Smartwatch performance for the detection and quantification of atrial fibrillation. Circ Arrhythmia Electrophysiol. 2019;12: e006834.CrossRef
39.
Selder JL, Breukel L, Blok S, van Rossum AC, Tulevski II, Allaart CP. A mobile one-lead ECG device incorporated in a symptom-driven remote arrhythmia monitoring program. The first 5,982 Hartwacht ECGs. Netherlands Hear J. 2019;27:38–45.
40.
Rozen G, Vaid J, Hosseini SM, Kaadan MI, Rafael A, Roka A, et al. Diagnostic accuracy of a novel mobile phone application for the detection and monitoring of atrial fibrillation. Am J Cardiol. 2018;121:1187–91.PubMedCrossRef
41.
Bumgarner JM, Lambert CT, Hussein AA, Cantillon DJ, Baranowski B, Wolski K, et al. Automated atrial fibrillation detection algorithm using smartwatch technology. J Am Coll Cardiol. 2018;71:2381–8.PubMedCrossRef
42.
Chan N-Y, Choy C-C, Chan C-K, Siu C-W. Effectiveness of a nongovernmental organization–led large-scale community atrial fibrillation screening program using the smartphone electrocardiogram: an observational cohort study. Hear Rhythm. 2018;15:1306–11.CrossRef
43.
Wegner FK, Kochhäuser S, Ellermann C, Lange PS, Frommeyer G, Leitz P, et al. Prospective blinded evaluation of the smartphone-based alivecor kardia ecg monitor for atrial fibrillation detection: the PEAK-AF study. Eur J Intern Med. 2020;73:72–5.PubMedCrossRef
44.
Haberman ZC, Jahn RT, Bose R, Tun H, Shinbane JS, Doshi RN, et al. Wireless smartphone ECG enables large-scale screening in diverse populations. J Cardiovasc Electrophysiol. 2015;26:520–6.PubMedCrossRef
45.
Poh M-Z, Poh YC, Chan P-H, Wong C-K, Pun L, Leung WW-C, et al. Diagnostic assessment of a deep learning system for detecting atrial fibrillation in pulse waveforms. Heart. 2018;104:1921–8.
46.
Santala OE, Lipponen JA, Jäntti H, Rissanen TT, Halonen J, Kolk I, et al. Necklace-embedded electrocardiogram for the detection and diagnosis of atrial fibrillation. Clin Cardiol. 2021;44:620–6.PubMedPubMedCentralCrossRef
47.
Jaakkola J, Jaakkola S, Lahdenoja O, Hurnanen T, Koivisto T, Pänkäälä M, et al. Mobile phone detection of atrial fibrillation with mechanocardiography: the MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation). Circulation. 2018;137:1524–7.PubMedCrossRef
48.
• Lown M, Yue AM, Shah BN, Corbett SJ, Lewith G, Stuart B, et al. Screening for atrial fibrillation using economical and accurate technology (from the safety study). Am J Cardiol. 2018;122:1339–44. Findings from this study suggest that wearable consumer ECG devices, Polar-H7 and Firstbeat Bodyguard 2, accurately and reliably detected atrial fibrillation in participants aged over 65. Their performance was comparable or superior to established devices, showing potential for affordable AF screening and management.
49.
Krivoshei L, Weber S, Burkard T, Maseli A, Brasier N, Kühne M, et al. Smart detection of atrial fibrillation. EP Eur. 2017;19:753–7.
50.
•• Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, Hummers E, Ivers N, et al. Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol. 2021;6:558–67. This study evaluated home-based atrial fibrillation (AF) screening interventions in individuals aged 75 or older with hypertension. Findings suggest that continuous electrocardiographic (cECG) patch monitoring and automated home blood pressure machines with AF screening capability can effectively detect AF, potentially increasing anticoagulant use for stroke prevention.
51.
Ha ACT, Verma S, Mazer CD, Quan A, Yanagawa B, Latter DA, et al. Effect of continuous electrocardiogram monitoring on detection of undiagnosed atrial fibrillation after hospitalization for cardiac surgery: a randomized clinical trial. JAMA Netw Open. 2021;4:e2121867–e2121867.PubMedCrossRef
52.
Steinhubl SR, Waalen J, Edwards AM, Ariniello LM, Mehta RR, Ebner GS, et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA. 2018;320:146–55.PubMedPubMedCentralCrossRef
53.
Tarakji KG, Wazni OM, Callahan T, Kanj M, Hakim AH, Wolski K, et al. Using a novel wireless system for monitoring patients after the atrial fibrillation ablation procedure: the iTransmit study. Hear Rhythm. 2015;12:554–9.CrossRef
54.
Channa A, Popescu N, Skibinska J, Burget R. The rise of wearable devices during the COVID-19 pandemic: a systematic review. Sensors. 2021;21:5787.PubMedPubMedCentralCrossRef
55.
56.
57.
Best J. Wearable technology: covid-19 and the rise of remote clinical monitoring. Bmj. 2021;372.
58.
59.
60.
61.
Gruwez H, Evens S, Proesmans T, Duncker D, Linz D, Heidbuchel H, et al. Accuracy of physicians interpreting photoplethysmography and electrocardiography tracings to detect atrial fibrillation: INTERPRET-AF. Front Cardiovasc Med. 2021:1122.
62.
63.
64.
Piwek L, Joinson A, Morvan J. The use of self-monitoring solutions amongst cyclists: an online survey and empirical study. Transp Res Part A Policy Pract. 2015;77:126–36.CrossRef
65.
Sultan N. Reflective thoughts on the potential and challenges of wearable technology for healthcare provision and medical education. Int J Inf Manage. 2015;35:521–6.CrossRef
66.
Castaneda D, Esparza A, Ghamari M, Soltanpur C, Nazeran H. A review on wearable photoplethysmography sensors and their potential future applications in health care. Int J Biosens Bioelectron. 2018;4:195.PubMedPubMedCentral
67.
Zinzuwadia A, Singh JP. Wearable devices—addressing bias and inequity. Lancet Digit Heal. 2022;4:e856–7.CrossRef
Metadaten
Titel
Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systematic Review
verfasst von
Faiza Babar
Abdul Manan Cheema
Zubair Ahmad
Azza Sarfraz
Zouina Sarfraz
Huma Ashraff
Hamnah Tayyab
Ali Mustafa Bajwa
Haider Ali
Muzna Sarfraz
Anum Shahzad
Syed Rafay Ali Sabzwari
Publikationsdatum
24.05.2023
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 7/2023
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-023-01898-3

Weitere Artikel der Ausgabe 7/2023

Current Cardiology Reports 7/2023 Zur Ausgabe

Psychological Aspects of Cardiovascular Diseases (IM Kronish, Section Editor)

Alexithymia and Hypertension: Does Personality Matter? A Systematic Review and Meta-analysis

Cardiovascular Genomics (KG Aragam, Section Editor)

Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis

Public Health Policy (SS Virani and D Mahtta, Section Editors)

Intracoronary Imaging and Physiology to Guide PCI: Are We Ready for a Class I Guideline Recommendation?

Ischemic Heart Disease (D Mukherjee, Section Editor)

Physical Activity and Mortality in Patients with Coronary Artery Disease

Public Health Policy (SS Virani and D Mahtta, Section Editors)

The Scope of Practice for Primary Cardiovascular Disease Prevention Expanded to Advanced Practice Providers: What Does the Data Show?

Regenerative Medicine (SM Wu, Section Editor)

Emerging Signaling Regulation of Sinoatrial Node Dysfunction

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen